Tenet Healthcare (THC) Misses Q2 EPS by 14c, Offers FY16 & Q3 Guidance

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $0.38, $0.14 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $4.87 billion versus the consensus estimate of $4.83 billion.

GUIDANCE:

Tenet Healthcare sees FY2016 EPS of $1.32-$1.67, versus the consensus of $1.93. Tenet Healthcare sees FY2016 revenue of $19.5-19.8 billion, versus the consensus of $19.4 billion.

Tenet Healthcare sees Q3 2016 EPS of $0.10-$0.25, may not compare to consensus of $0.43. Tenet Healthcare sees Q3 2016 revenue of $4.75-4.85 billion, versus the consensus of $4.7 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth